Trial Profile
A Phase 3 study of S-474474 in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Irbesartan/trichlormethiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Shionogi
- 02 Jun 2016 New trial record